375 related articles for article (PubMed ID: 34019811)
21. ARH Family of ADP-Ribose-Acceptor Hydrolases.
Ishiwata-Endo H; Kato J; Yamashita S; Chea C; Koike K; Lee DY; Moss J
Cells; 2022 Nov; 11(23):. PubMed ID: 36497109
[TBL] [Abstract][Full Text] [Related]
22. The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase.
Slade D; Dunstan MS; Barkauskaite E; Weston R; Lafite P; Dixon N; Ahel M; Leys D; Ahel I
Nature; 2011 Sep; 477(7366):616-20. PubMed ID: 21892188
[TBL] [Abstract][Full Text] [Related]
23. Serine ADP-ribosylation in Drosophila provides insights into the evolution of reversible ADP-ribosylation signalling.
Fontana P; Buch-Larsen SC; Suyari O; Smith R; Suskiewicz MJ; Schützenhofer K; Ariza A; Rack JGM; Nielsen ML; Ahel I
Nat Commun; 2023 Jun; 14(1):3200. PubMed ID: 37268618
[TBL] [Abstract][Full Text] [Related]
24. A quantitative assay reveals ligand specificity of the DNA scaffold repair protein XRCC1 and efficient disassembly of complexes of XRCC1 and the poly(ADP-ribose) polymerase 1 by poly(ADP-ribose) glycohydrolase.
Kim IK; Stegeman RA; Brosey CA; Ellenberger T
J Biol Chem; 2015 Feb; 290(6):3775-83. PubMed ID: 25477519
[TBL] [Abstract][Full Text] [Related]
25. Structural and biochemical analysis of human ADP-ribosyl-acceptor hydrolase 3 reveals the basis of metal selectivity and different roles for the two magnesium ions.
Pourfarjam Y; Ma Z; Kurinov I; Moss J; Kim IK
J Biol Chem; 2021; 296():100692. PubMed ID: 33894202
[TBL] [Abstract][Full Text] [Related]
26. PARG Inhibitors and Functional PARG Inhibition Models.
Sasaki Y; Hozumi M; Fujimori H; Murakami Y; Koizumi F; Inoue K; Masutani M
Curr Protein Pept Sci; 2016; 17(7):641-653. PubMed ID: 27817742
[TBL] [Abstract][Full Text] [Related]
27. ADP-Ribosylation and Antiviral Resistance in Plants.
Spechenkova N; Kalinina NO; Zavriev SK; Love AJ; Taliansky M
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680280
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of poly(ADP-ribose) polymerase-1 or poly(ADP‑ribose) glycohydrolase individually, but not in combination, leads to improved chemotherapeutic efficacy in HeLa cells.
Feng X; Koh DW
Int J Oncol; 2013 Feb; 42(2):749-56. PubMed ID: 23254695
[TBL] [Abstract][Full Text] [Related]
29. An Enzyme-Linked Immunosorbent Assay to Quantify Poly (ADP-Ribose) Level In Vivo.
Ida C; Yamashita S; Eguchi T; Kuroda Y; Nakae S; Nishi Y; Kamemura K; Shirai T; Mizukami T; Tanaka M; Moss J; Miwa M
Methods Mol Biol; 2023; 2609():91-100. PubMed ID: 36515831
[TBL] [Abstract][Full Text] [Related]
30. Altered poly(ADP-ribose) metabolism impairs cellular responses to genotoxic stress in a hypomorphic mutant of poly(ADP-ribose) glycohydrolase.
Gao H; Coyle DL; Meyer-Ficca ML; Meyer RG; Jacobson EL; Wang ZQ; Jacobson MK
Exp Cell Res; 2007 Mar; 313(5):984-96. PubMed ID: 17276427
[TBL] [Abstract][Full Text] [Related]
31. Mammalian N1-adenosine PARylation is a reversible DNA modification.
Musheev MU; Schomacher L; Basu A; Han D; Krebs L; Scholz C; Niehrs C
Nat Commun; 2022 Oct; 13(1):6138. PubMed ID: 36253381
[TBL] [Abstract][Full Text] [Related]
32. MARTs and MARylation in the Cytosol: Biological Functions, Mechanisms of Action, and Therapeutic Potential.
Challa S; Stokes MS; Kraus WL
Cells; 2021 Feb; 10(2):. PubMed ID: 33546365
[TBL] [Abstract][Full Text] [Related]
33. Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease.
Sharifi R; Morra R; Appel CD; Tallis M; Chioza B; Jankevicius G; Simpson MA; Matic I; Ozkan E; Golia B; Schellenberg MJ; Weston R; Williams JG; Rossi MN; Galehdari H; Krahn J; Wan A; Trembath RC; Crosby AH; Ahel D; Hay R; Ladurner AG; Timinszky G; Williams RS; Ahel I
EMBO J; 2013 May; 32(9):1225-37. PubMed ID: 23481255
[TBL] [Abstract][Full Text] [Related]
34. Drosophila poly(ADP-ribose) glycohydrolase mediates chromatin structure and SIR2-dependent silencing.
Tulin A; Naumova NM; Menon AK; Spradling AC
Genetics; 2006 Jan; 172(1):363-71. PubMed ID: 16219773
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Poly (ADP-Ribose) Glycohydrolase Accelerates Osteoblast Differentiation in Preosteoblastic MC3T3-E1 Cells.
Sasaki Y; Nakatsuka R; Inouchi T; Masutani M; Nozaki T
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563432
[TBL] [Abstract][Full Text] [Related]
36. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro.
Lin KY; Huang D; Kraus WL
Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863
[TBL] [Abstract][Full Text] [Related]
37. Specific killing of DNA damage-response deficient cells with inhibitors of poly(ADP-ribose) glycohydrolase.
Gravells P; Grant E; Smith KM; James DI; Bryant HE
DNA Repair (Amst); 2017 Apr; 52():81-91. PubMed ID: 28254358
[TBL] [Abstract][Full Text] [Related]
38. Functional localization of two poly(ADP-ribose)-degrading enzymes to the mitochondrial matrix.
Niere M; Kernstock S; Koch-Nolte F; Ziegler M
Mol Cell Biol; 2008 Jan; 28(2):814-24. PubMed ID: 17991898
[TBL] [Abstract][Full Text] [Related]
39. Poly(ADP-ribosyl)ation is a survival mechanism in cigarette smoke-induced and hydrogen peroxide-mediated cell death.
Kovács K; Erdélyi K; Hegedűs C; Lakatos P; Regdon Z; Bai P; Haskó G; Szabó E; Virág L
Free Radic Biol Med; 2012 Nov; 53(9):1680-8. PubMed ID: 22964577
[TBL] [Abstract][Full Text] [Related]
40. Structure of human ADP-ribosyl-acceptor hydrolase 3 bound to ADP-ribose reveals a conformational switch that enables specific substrate recognition.
Pourfarjam Y; Ventura J; Kurinov I; Cho A; Moss J; Kim IK
J Biol Chem; 2018 Aug; 293(32):12350-12359. PubMed ID: 29907568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
